BDRX - Biodexa shares rally 126% on rapamycin licensing deal
2024-04-26 09:56:33 ET
More on Biodexa Pharmaceuticals, Gilead Sciences, etc.
- Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcript
- Gilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?
- Dividend Roundup: MetLife, General Motors, Pfizer, Citigroup, and more
- Gilead has strong Q1, but updated 2024 EPS guidance range misses consensus